Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
When researchers design a protein expression study, the standard toolkit of IHC, IF, flow cytometry, and other techniques can tell them a great deal about where a protein is and how much of it is... Read more
Organoid research has grown substantially over the past decade and a half. What started with self-organizing intestinal epithelium in basement membrane extract has expanded into a platform used across cancer biology, infectious disease, developmental biology,... Read more
Two Vector scientists were recently interviewed about glycosylation in cancer research and advances in bioconjugation for next-generation therapeutics.
Vector Laboratories will be attending Cancer Glyco-X 2026 to discuss how the right tools reveal glyco-insights in cancer research. Product Manager Shuhui Chen and Sr. Field Application Scientist Sabrina Mateos will be representing Vector Laboratories... Read more
Immune checkpoint therapy describes a class of antibody therapeutics for the treatment of cancer that target proteins that modulate immune responses. More than a dozen approved therapeutics target immune checkpoint proteins like PD-1, PD-L1, and... Read more
Looking Beyond Genes and Proteins Genomics has transformed how we identify disease, and proteomics has expanded how we understand function. But in Congenital Disorders of Glycosylation (CDGs), neither tells the full story. CDGs arise from... Read more
We’re excited to share that Vector Laboratories and VectaPlex™ Antibody Removal Kit were featured in the Biocompare article, “Traditional vs. Multiplex Immunohistochemistry.” The piece highlights the need for multiplexing in tissue analysis and outlines how... Read more
Join us at booth #603 to explore cancer detection, targeting, and biomarker research solutions powered by 50 years of expertise. At the AACR Annual Meeting 2026 in San Diego, Vector Laboratories is showcasing how its... Read more
Probing protein glycosylation uncovers new diagnostic and therapeutic avenues for breast cancer, one of the most common forms of cancer.
As colorectal cancer research continues to shift toward precision approaches, the ability to accurately detect and characterize key biomarkers is more important than ever.
